SWEDISH ORPHAN/S (OTCMKTS:SWTUY – Get Free Report) dropped 1.2% during mid-day trading on Tuesday . The stock traded as low as $24.38 and last traded at $24.38. Approximately 200 shares were traded during mid-day trading, a decline of 88% from the average daily volume of 1,665 shares. The stock had previously closed at $24.67.
SWEDISH ORPHAN/S Trading Down 1.2%
The firm has a 50-day moving average of $24.38 and a 200-day moving average of $24.38. The stock has a market capitalization of $6.64 billion, a price-to-earnings ratio of 48.76, a P/E/G ratio of 1.30 and a beta of 1.81.
About SWEDISH ORPHAN/S
Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, inflammation, and genetic and lysosomal diseases. The company offers Elocta to treat haemophilia A; and Alprolix to treat haemophilia B.
See Also
- Five stocks we like better than SWEDISH ORPHAN/S
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- 3 Potential Scenarios to Watch for in D-Wave’s Earnings Report
- Find and Profitably Trade Stocks at 52-Week Lows
- Eli Lilly Posts Stellar Q3: Long-Term Upside Is Well in Play
- What is an Earnings Surprise?
- Uber Is Crushing Lyft—And It’s Not Even Close
Receive News & Ratings for SWEDISH ORPHAN/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SWEDISH ORPHAN/S and related companies with MarketBeat.com's FREE daily email newsletter.
